Sino Biopharmaceutical Limited (HKG:1177)
Hong Kong · Delayed Price · Currency is HKD 4.975
-0.375 (-7.01%)
Oct 22, 2026, 2:05 PM HKT
Sino Biopharmaceutical Market Cap
Sino Biopharmaceutical has a market cap or net worth of 88.6 billion as of October 21, 2026. It is the 1,902nd most valuable company in the world and the 100th biggest in Hong Kong. Its market cap has decreased by 33.02% in one year.
Market Cap
88.60B
Enterprise Value
92.38B
Revenue
38.91B
Global Rank
Country Rank
#100 Hong Kong
PE Ratio
32.46
ChartMarket Cap Chart
Since September 29, 2000, Sino Biopharmaceutical's market cap has increased from 329.97M to 88.60B, an increase of 26,752.03%. That is a compound annual growth rate of 23.92%.
| Date | Market Cap | % Change |
|---|---|---|
| Oct 22, 2026 | 88.60B | -19.80% |
| Dec 31, 2025 | 110.48B | 89.64% |
| Dec 31, 2024 | 58.26B | -8.75% |
| Dec 29, 2023 | 63.85B | -24.41% |
| Dec 30, 2022 | 84.46B | -17.53% |
| Dec 31, 2021 | 102.41B | -27.33% |
| Dec 31, 2020 | Upgrade Pro | Upgrade Pro |
| Dec 31, 2019 | Upgrade Pro | Upgrade Pro |
| Dec 31, 2018 | Upgrade Pro | Upgrade Pro |
| Dec 29, 2017 | Upgrade Pro | Upgrade Pro |
| Dec 30, 2016 | Upgrade Pro | Upgrade Pro |
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Related Stocks
| Company | Market Cap |
|---|---|
| WuXi Biologics | 182.70B |
| Innovent Biologics | 141.62B |
| Sichuan Kelun-Biotech Biopharmaceutical | 106.60B |
| Akeso | 78.91B |
| Genscript Biotech | 73.16B |
| RemeGen | 52.46B |
| Biocytogen Pharmaceuticals (Beijing) | 35.50B |
| 3SBio | 33.79B |